The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients

Accumulated evidence suggest that the adverse outcome of severe coronavirus disease 2019 (COVID-19) is closely related to prothrombotic microvascular pathology with a high risk of venous thromboembolism. Furthermore, the first observational studies indicated that adjunct therapy with low-molecular w...

Descripción completa

Detalles Bibliográficos
Autores principales: Reichman-Warmusz, Edyta, Warmusz, Oliwia, Wojnicz, Romuald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Mini-Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812716/
https://www.ncbi.nlm.nih.gov/pubmed/35178474
http://dx.doi.org/10.1515/med-2021-0374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812716/
https://www.ncbi.nlm.nih.gov/pubmed/35178474
http://dx.doi.org/10.1515/med-2021-0374

Ejemplares similares